Selected research
Industry Research
Peptide Conjugates Service Industry Research Report 2026
Market perspective
The global Peptide Conjugates Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Peptide Conjugates Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Peptide Conjugates Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Peptide Conjugates Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Peptide Conjugates Service include Almac Group, Bio-Synthesis, Creative Peptides, ProtaGene GmbH, WuXi TIDES, Medtide Inc, Ajinomoto, PHARMARON and SBS Genetech, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Peptide Conjugates Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Peptide Conjugates Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Peptide Conjugates Service Market by Company
Almac Group
Bio-Synthesis
Creative Peptides
ProtaGene GmbH
WuXi TIDES
Medtide Inc
Ajinomoto
PHARMARON
SBS Genetech
Creative Enzymes
AnaSpec
BOCSCI Inc
JPT Peptide Technologies
Kaneka Eurogentec SA
QYAOBIO
Peptide Conjugates Service Segment by Type
Peptide Oligonucleotide Conjugates
Peptide Carrier Protein Conjugates
Peptide Small Molecule Conjugates
Other
Peptide Conjugates Service Segment by Application
Vaccine Development
Drug Delivery
Biomarkers
Peptide Conjugates Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptide Conjugates Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Peptide Conjugates Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptide Conjugates Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Peptide Conjugates Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Peptide Oligonucleotide Conjugates
- Peptide Carrier Protein Conjugates
- Peptide Small Molecule Conjugates
- Other
Applications
- Vaccine Development
- Drug Delivery
- Biomarkers
Companies covered
- Almac Group
- Bio-Synthesis
- Creative Peptides
- ProtaGene GmbH
- WuXi TIDES
- Medtide Inc
- Ajinomoto
- PHARMARON
- SBS Genetech
- Creative Enzymes
- AnaSpec
- BOCSCI Inc
- JPT Peptide Technologies
- Kaneka Eurogentec SA
- QYAOBIO
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Peptide Conjugates Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Peptide Oligonucleotide Conjugates
- 2.2.3 Peptide Carrier Protein Conjugates
- 2.2.4 Peptide Small Molecule Conjugates
- 2.2.5 Other
- 2.3 Peptide Conjugates Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Vaccine Development
- 2.3.3 Drug Delivery
- 2.3.4 Biomarkers
- 2.4 Assumptions and Limitations
3 Peptide Conjugates Service Breakdown Data by Type
- 3.1 Global Peptide Conjugates Service Historic Market Size by Type (2021-2026)
- 3.2 Global Peptide Conjugates Service Forecasted Market Size by Type (2027-2032)
4 Peptide Conjugates Service Breakdown Data by Application
- 4.1 Global Peptide Conjugates Service Historic Market Size by Application (2021-2026)
- 4.2 Global Peptide Conjugates Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Peptide Conjugates Service Market Perspective (2021-2032)
- 5.2 Global Peptide Conjugates Service Growth Trends by Region
- 5.2.1 Global Peptide Conjugates Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Peptide Conjugates Service Historic Market Size by Region (2021-2026)
- 5.2.3 Peptide Conjugates Service Forecasted Market Size by Region (2027-2032)
- 5.3 Peptide Conjugates Service Market Dynamics
- 5.3.1 Peptide Conjugates Service Industry Trends
- 5.3.2 Peptide Conjugates Service Market Drivers
- 5.3.3 Peptide Conjugates Service Market Challenges
- 5.3.4 Peptide Conjugates Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Peptide Conjugates Service Players by Revenue
- 6.1.1 Global Top Peptide Conjugates Service Players by Revenue (2021-2026)
- 6.1.2 Global Peptide Conjugates Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Peptide Conjugates Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Peptide Conjugates Service Head Office and Area Served
- 6.4 Global Peptide Conjugates Service Players, Product Type & Application
- 6.5 Global Peptide Conjugates Service Manufacturers Established Date
- 6.6 Global Peptide Conjugates Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Peptide Conjugates Service Market Size (2021-2032)
- 7.2 North America Peptide Conjugates Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Peptide Conjugates Service Market Size by Country (2021-2026)
- 7.4 North America Peptide Conjugates Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Peptide Conjugates Service Market Size (2021-2032)
- 8.2 Europe Peptide Conjugates Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Peptide Conjugates Service Market Size by Country (2021-2026)
- 8.4 Europe Peptide Conjugates Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Peptide Conjugates Service Market Size (2021-2032)
- 9.2 Asia-Pacific Peptide Conjugates Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Peptide Conjugates Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Peptide Conjugates Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Peptide Conjugates Service Market Size (2021-2032)
- 10.2 South America Peptide Conjugates Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Peptide Conjugates Service Market Size by Country (2021-2026)
- 10.4 South America Peptide Conjugates Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Peptide Conjugates Service Market Size (2021-2032)
- 11.2 Middle East & Africa Peptide Conjugates Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Peptide Conjugates Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Peptide Conjugates Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Almac Group
- 12.1.1 Almac Group Company Information
- 12.1.2 Almac Group Business Overview
- 12.1.3 Almac Group Revenue in Peptide Conjugates Service Business (2021-2026)
- 12.1.4 Almac Group Peptide Conjugates Service Product Portfolio
- 12.1.5 Almac Group Recent Developments
- 12.2 Bio-Synthesis
- 12.2.1 Bio-Synthesis Company Information
- 12.2.2 Bio-Synthesis Business Overview
- 12.2.3 Bio-Synthesis Revenue in Peptide Conjugates Service Business (2021-2026)
- 12.2.4 Bio-Synthesis Peptide Conjugates Service Product Portfolio
- 12.2.5 Bio-Synthesis Recent Developments
- 12.3 Creative Peptides
- 12.3.1 Creative Peptides Company Information
- 12.3.2 Creative Peptides Business Overview
- 12.3.3 Creative Peptides Revenue in Peptide Conjugates Service Business (2021-2026)
- 12.3.4 Creative Peptides Peptide Conjugates Service Product Portfolio
- 12.3.5 Creative Peptides Recent Developments
- 12.4 ProtaGene GmbH
- 12.4.1 ProtaGene GmbH Company Information
- 12.4.2 ProtaGene GmbH Business Overview
- 12.4.3 ProtaGene GmbH Revenue in Peptide Conjugates Service Business (2021-2026)
- 12.4.4 ProtaGene GmbH Peptide Conjugates Service Product Portfolio
- 12.4.5 ProtaGene GmbH Recent Developments
- 12.5 WuXi TIDES
- 12.5.1 WuXi TIDES Company Information
- 12.5.2 WuXi TIDES Business Overview
- 12.5.3 WuXi TIDES Revenue in Peptide Conjugates Service Business (2021-2026)
- 12.5.4 WuXi TIDES Peptide Conjugates Service Product Portfolio
- 12.5.5 WuXi TIDES Recent Developments
- 12.6 Medtide Inc
- 12.6.1 Medtide Inc Company Information
- 12.6.2 Medtide Inc Business Overview
- 12.6.3 Medtide Inc Revenue in Peptide Conjugates Service Business (2021-2026)
- 12.6.4 Medtide Inc Peptide Conjugates Service Product Portfolio
- 12.6.5 Medtide Inc Recent Developments
- 12.7 Ajinomoto
- 12.7.1 Ajinomoto Company Information
- 12.7.2 Ajinomoto Business Overview
- 12.7.3 Ajinomoto Revenue in Peptide Conjugates Service Business (2021-2026)
- 12.7.4 Ajinomoto Peptide Conjugates Service Product Portfolio
- 12.7.5 Ajinomoto Recent Developments
- 12.8 PHARMARON
- 12.8.1 PHARMARON Company Information
- 12.8.2 PHARMARON Business Overview
- 12.8.3 PHARMARON Revenue in Peptide Conjugates Service Business (2021-2026)
- 12.8.4 PHARMARON Peptide Conjugates Service Product Portfolio
- 12.8.5 PHARMARON Recent Developments
- 12.9 SBS Genetech
- 12.9.1 SBS Genetech Company Information
- 12.9.2 SBS Genetech Business Overview
- 12.9.3 SBS Genetech Revenue in Peptide Conjugates Service Business (2021-2026)
- 12.9.4 SBS Genetech Peptide Conjugates Service Product Portfolio
- 12.9.5 SBS Genetech Recent Developments
- 12.10 Creative Enzymes
- 12.10.1 Creative Enzymes Company Information
- 12.10.2 Creative Enzymes Business Overview
- 12.10.3 Creative Enzymes Revenue in Peptide Conjugates Service Business (2021-2026)
- 12.10.4 Creative Enzymes Peptide Conjugates Service Product Portfolio
- 12.10.5 Creative Enzymes Recent Developments
- 12.11 AnaSpec
- 12.11.1 AnaSpec Company Information
- 12.11.2 AnaSpec Business Overview
- 12.11.3 AnaSpec Revenue in Peptide Conjugates Service Business (2021-2026)
- 12.11.4 AnaSpec Peptide Conjugates Service Product Portfolio
- 12.11.5 AnaSpec Recent Developments
- 12.12 BOCSCI Inc
- 12.12.1 BOCSCI Inc Company Information
- 12.12.2 BOCSCI Inc Business Overview
- 12.12.3 BOCSCI Inc Revenue in Peptide Conjugates Service Business (2021-2026)
- 12.12.4 BOCSCI Inc Peptide Conjugates Service Product Portfolio
- 12.12.5 BOCSCI Inc Recent Developments
- 12.13 JPT Peptide Technologies
- 12.13.1 JPT Peptide Technologies Company Information
- 12.13.2 JPT Peptide Technologies Business Overview
- 12.13.3 JPT Peptide Technologies Revenue in Peptide Conjugates Service Business (2021-2026)
- 12.13.4 JPT Peptide Technologies Peptide Conjugates Service Product Portfolio
- 12.13.5 JPT Peptide Technologies Recent Developments
- 12.14 Kaneka Eurogentec SA
- 12.14.1 Kaneka Eurogentec SA Company Information
- 12.14.2 Kaneka Eurogentec SA Business Overview
- 12.14.3 Kaneka Eurogentec SA Revenue in Peptide Conjugates Service Business (2021-2026)
- 12.14.4 Kaneka Eurogentec SA Peptide Conjugates Service Product Portfolio
- 12.14.5 Kaneka Eurogentec SA Recent Developments
- 12.15 QYAOBIO
- 12.15.1 QYAOBIO Company Information
- 12.15.2 QYAOBIO Business Overview
- 12.15.3 QYAOBIO Revenue in Peptide Conjugates Service Business (2021-2026)
- 12.15.4 QYAOBIO Peptide Conjugates Service Product Portfolio
- 12.15.5 QYAOBIO Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst